vs
Side-by-side financial comparison of AMERICAN BATTERY TECHNOLOGY Co (ABAT) and Foghorn Therapeutics Inc. (FHTX). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $4.8M, roughly 1.9× AMERICAN BATTERY TECHNOLOGY Co). AMERICAN BATTERY TECHNOLOGY Co runs the higher net margin — -195.0% vs -234.3%, a 39.3% gap on every dollar of revenue. On growth, AMERICAN BATTERY TECHNOLOGY Co posted the faster year-over-year revenue change (1331.8% vs 223.8%).
American Battery Technology Company, formerly American Battery Metals Corporation, is a US-based battery recycling technology startup founded in 2011. It employs a hydrometallurgical process to recycle batteries and a targeted extraction system to extract raw materials from primary resources.
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
ABAT vs FHTX — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.8M | $9.2M |
| Net Profit | $-9.3M | $-21.7M |
| Gross Margin | -33.6% | — |
| Operating Margin | -207.5% | -258.2% |
| Net Margin | -195.0% | -234.3% |
| Revenue YoY | 1331.8% | 223.8% |
| Net Profit YoY | 30.7% | -11.1% |
| EPS (diluted) | $-0.07 | $-0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.8M | $9.2M | ||
| Q3 25 | $937.6K | $8.2M | ||
| Q2 25 | $2.8M | $7.6M | ||
| Q1 25 | $980.0K | $6.0M | ||
| Q4 24 | — | $2.9M | ||
| Q3 24 | — | $7.8M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | — | $5.0M |
| Q4 25 | $-9.3M | $-21.7M | ||
| Q3 25 | $-10.3M | $-15.8M | ||
| Q2 25 | $-10.2M | $-17.9M | ||
| Q1 25 | $-11.5M | $-18.8M | ||
| Q4 24 | — | $-19.5M | ||
| Q3 24 | — | $-19.1M | ||
| Q2 24 | — | $-23.0M | ||
| Q1 24 | — | $-25.0M |
| Q4 25 | -33.6% | — | ||
| Q3 25 | -375.1% | — | ||
| Q2 25 | -92.6% | — | ||
| Q1 25 | -274.5% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -207.5% | -258.2% | ||
| Q3 25 | -1080.8% | -226.9% | ||
| Q2 25 | -280.1% | -279.2% | ||
| Q1 25 | -1086.3% | -385.0% | ||
| Q4 24 | — | -840.5% | ||
| Q3 24 | — | -305.5% | ||
| Q2 24 | — | -386.6% | ||
| Q1 24 | — | -558.3% |
| Q4 25 | -195.0% | -234.3% | ||
| Q3 25 | -1098.5% | -194.4% | ||
| Q2 25 | -366.4% | -237.3% | ||
| Q1 25 | -1173.1% | -316.4% | ||
| Q4 24 | — | -682.9% | ||
| Q3 24 | — | -244.9% | ||
| Q2 24 | — | -333.6% | ||
| Q1 24 | — | -495.4% |
| Q4 25 | $-0.07 | $-0.35 | ||
| Q3 25 | $-0.09 | $-0.25 | ||
| Q2 25 | $-0.09 | $-0.28 | ||
| Q1 25 | $-0.14 | $-0.30 | ||
| Q4 24 | — | $-0.23 | ||
| Q3 24 | — | $-0.31 | ||
| Q2 24 | — | $-0.45 | ||
| Q1 24 | — | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $47.9M | $80.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $119.0M | $-108.5M |
| Total Assets | $123.3M | $198.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $47.9M | $80.9M | ||
| Q3 25 | $30.9M | $89.3M | ||
| Q2 25 | $7.5M | $72.6M | ||
| Q1 25 | $7.8M | $61.0M | ||
| Q4 24 | — | $55.5M | ||
| Q3 24 | — | $57.7M | ||
| Q2 24 | — | $138.9M | ||
| Q1 24 | — | $79.3M |
| Q4 25 | $119.0M | $-108.5M | ||
| Q3 25 | $96.0M | $-89.7M | ||
| Q2 25 | $70.6M | $-76.7M | ||
| Q1 25 | $65.6M | $-61.7M | ||
| Q4 24 | — | $-45.5M | ||
| Q3 24 | — | $-28.3M | ||
| Q2 24 | — | $-14.3M | ||
| Q1 24 | — | $-97.5M |
| Q4 25 | $123.3M | $198.1M | ||
| Q3 25 | $101.5M | $205.0M | ||
| Q2 25 | $84.5M | $226.2M | ||
| Q1 25 | $76.5M | $258.7M | ||
| Q4 24 | — | $284.0M | ||
| Q3 24 | — | $308.4M | ||
| Q2 24 | — | $328.6M | ||
| Q1 24 | — | $255.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-9.8M | $-22.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-9.8M | $-22.3M | ||
| Q3 25 | $-7.1M | $-18.9M | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | $-10.3M | $-24.0M | ||
| Q4 24 | — | $-24.5M | ||
| Q3 24 | — | $-21.0M | ||
| Q2 24 | — | $-25.5M | ||
| Q1 24 | — | $-29.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-21.0M | ||
| Q1 25 | — | $-24.0M | ||
| Q4 24 | — | $-25.0M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-25.6M | ||
| Q1 24 | — | $-29.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -278.2% | ||
| Q1 25 | — | -403.2% | ||
| Q4 24 | — | -875.3% | ||
| Q3 24 | — | -273.0% | ||
| Q2 24 | — | -371.0% | ||
| Q1 24 | — | -583.1% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 16.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 2.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
